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Evaluation of an in vitro assay 
to screen for the immunotoxic 
potential of chemicals to fish
Kristina Rehberger1*, Beate I. Escher2,3, Andreas Scheidegger4, Inge Werner5 & 
Helmut Segner1
A wide variety of environmental contaminants has been shown to disrupt immune functions 
of fish and may compromise their defense capability against pathogens. Immunotoxic effects, 
however, are rarely considered in ecotoxicological testing strategies. The aim of this study was 
to systematically evaluate the suitability of an in vitro immuno-assay using selected fish immune 
parameters to screen for chemicals with known immunotoxic potential and to differentiate them 
from non-immunotoxicants. Non-stimulated and lipopolysaccharide-stimulated head kidney 
leukocytes of rainbow trout (Oncorhynchus mykiss) were exposed for 3 h or 19 h to chemicals with 
different modes of action. As immune parameters, phagocytosis activity, oxidative burst activity and 
cytokine transcription (IL-1β, TNFα, IL-10) were examined, accompanied by in silico modelling. The 
immunotoxicants dexamethasone, benzo(a)pyrene, ethinylestradiol and bisphenol A significantly 
altered the immune parameters at non-cytotoxic concentrations whereas diclofenac had only weak 
effects. However, the two baseline chemicals with no known immunotoxic potential, butanol and 
ethylene glycol, caused significant effects, too. From our results it appears that the in vitro fish 
leukocyte assay as performed in the present study has only a limited capacity for discriminating 
between immunotoxicants and non-immunotoxicants.
A wide variety of environmental contaminants has been shown to disrupt immune functions of wildlife spe-
cies. Such immunotoxic activities bear ecological relevance since efficient immunocompetence is a critical fit-
ness determinant enabling the organism to survive, to minimize the fitness costs of infection and to maintain 
good growth and  reproduction1–5. For teleost fish populations living in polluted environments, numerous field 
observations indicate alterations of immune parameters and/or increased disease  incidences6–13. Environmental 
contaminants that are known to disrupt the immune system of fish include dioxin-like chemicals or polycy-
clic aromatic  hydrocarbons14–21, endocrine-disrupting  compounds22–29 and pharmaceuticals like the pain killer, 
diclofenac (DCF) or the anti-inflammatory drug, dexamethasone (Dex)30–33.
Valid diagnostic and testing methods are crucial for assessing the hazard and risk arising from immunotoxic 
chemicals. In human toxicology, regulatory guidelines containing standardized and validated methods for the 
assessment of immunotoxic activities of chemicals have evolved from the 1980s (cf.34–37). In line with the recent 
paradigm shift in toxicology (Toxicology in the twenty-first  century38), increasing attention is given to the use 
of in vitro  assays39–42. Although they cannot provide a definitive assessment of adverse immune effects, they 
can screen potential immunotoxic activities and prioritize positive compounds for further testing (e.g.40,41,43,44).
We recently reviewed the literature for tests and endpoints used in immunotoxicity studies with  fish45. The 
most frequently analyzed immune parameters were (I) phagocytosis activity (II) respiratory burst activity and 
(III) immune genes, mainly immune mediators like cytokines at mRNA level. Phagocytosis and oxidative burst 
are of physiological importance since they are key mechanisms of the innate immune system, which is of particu-
lar relevance in fish and, additionally, is well conserved across species. Randelli et al.46 mentioned phagocytosis 
and respiratory burst activity as suitable marker for fish innate immunity and Fournier et al.47 highlighted the 
phagocytosis assay as a suitable biomarker for immunotoxic effects in wildlife populations. The most frequently 
measured immune genes in fish immunotoxicity studies were cytokines, i.e. interleukins (IL) and tumor necrosis 
factor (TNF)45. Cytokines are important signaling proteins orchestrating the immune  response48. Among the 
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pro-inflammatory cytokines, IL-1 was evaluated most frequently in fish immunotoxicity studies; among the anti-
inflammatory cytokines, it was IL-1045. All these parameters used in fish immunotoxicity studies—phagocytosis 
activity, oxidative burst activity, transcription of cytokines—can principally be assessed in in vitro assays using 
isolated fish leukocytes. Such an assay therefore could be a prime candidate for screening of chemicals with 
immunotoxic potential in fish. However, a systematic evaluation of the ability of an in vitro fish leukocyte assay to 
detect immunotoxicants and to discriminate them from non-immunotoxicants has not been undertaken to date.
The aim of the present study was to examine if an in vitro fish leukocyte assay is a suitable tool to screen for 
immunotoxic potentials of environmental chemicals to fish. We hypothesised that at least one immune parameter 
measured in this assay—phagocytosis, respiratory burst activity or cytokine transcripts—would be responsive to 
immunotoxicants while none of the immune parameters would respond to non-immunotoxicants (Table 1). We 
used leukocytes isolated from the head kidney (HK, a major fish immune organ) of female, non-exposed rainbow 
trout (Oncorhynchus mykiss). Since the immune system reactivity can differ between the resting and activated 
 state49 evaluations were carried out concurrently with non-stimulated leukocytes and with leukocytes stimulated 
by bacterial lipopolysaccharide (LPS). Chemical exposure was conducted in vitro for 3 h or 19 h. The tested 
immunotoxic chemicals included compounds that interfere with the immune system through different modes 
of action. All tests were performed at sub-cytotoxic concentrations in order to avoid false positive responses of 
the immunological parameters caused by adverse effects of high concentrations of test chemicals on cell viability 
(cf.50). In vitro effect concentrations were compared with in silico predictions for baseline  cytotoxicity51 to identify 
how much more potent the specific effects were in comparison to baseline  cytotoxicity52. Importantly, the purpose 
using this in vitro assay was neither to predict adverse outcomes nor toxic effect concentrations in whole fish but 
to screen for chemicals with immunotoxic potential and to discriminate them from non-immunotoxic chemicals.
Methods
Test chemicals and reagents. Test chemicals are listed in Table 1 including references providing infor-
mation on their molecular initiating events (MIE)/mode of action (MoA) as well as references describing the 
immunotoxic activity of these compounds in fish. Dexamethasone (Dex) was used as reference compound 
since it is a well-established immunosuppressive agent for fish. Other immunotoxicants were diclofenac (DCF), 
benzo(a)pyrene (BaP), bisphenol A (BPA) and 17α-ethinylestradiol (EE2). The selection criteria for the three 
non-immunotoxic chemicals—ethylene glycol (EG), 1-butanol (But), 1,2,4-trichlorobenzene (TCB)—are pro-
vided in Table 1, too. For those chemicals we did not find any indication that they possess an immunotoxic activ-
ity (key words for the literature search in the Supplementary Material S1a) and they are categorized as baseline/
narcotic compounds. For trichlorobenzene, the immuno-assay was conducted but the results were excluded 
retrospectively, since the QASR modelling revealed a loss to air of about 90%. Detailed information on the 
chemicals and reagents used is provided in Supplementary Material S1b. For the chemical exposure, stock solu-
tions were prepared as followed (chemicals in alphabetic order): benzo(a)pyrene: 1 mM in acetonitrile, stored 
in aliquots at − 20 °C; bisphenol A: 500 µM in medium, stored in aliquots at − 20 °C; butanol: no stock solution 
prepared; dexamethasone: 25.45 mM in methanol; diclofenac: 5 mM in water, stored in aliquots at − 20  °C; 
ethinylestradiol: 8 mM in ethanol; ethylene glycol: no stock solution prepared; trichlorobenzene: 27.56 mM in 
ethanol. The required test concentrations were achieved by dilution with medium. If a solvent was required for 
preparation of the chemical solutions, a solvent-containing (below 0.1%) control was included in the immuno-
assay in addition to the solvent-free control. Although presented data was normalized to the solvent control (if 
Table 1.  Nominal concentrations of chemicals for assessing the immune parameters, and their molecular 
initiating event (MIE)/mode of action (MoA). MeOH methanol, AcN acetonitrile, EtOH ethanol, GR 
glucocorticoid receptor, COX cyclooxygenase, AhR aryl hydrocarbon receptor, ER estrogen receptor, PPAR 
peroxisome proliferator-activated receptor, NF-κB nuclear factor kappa-light-chain-enhancer of activated B 
cells. *TCB: the immuno-assay was conducted but results were excluded retrospectively since QASR modelling 








Reference supporting the 
immunotoxic action in fish
Dexamethasone (Dex) 0, 1, 5, 10 µM solvent: MeOH GR
124,125 Yes 31–33
Diclofenac (DCF) 0, 1, 5, 10, 50 µM COX 107 Yes 30,32
Benzo(a)pyrene (BaP) 0, 0.1, 0.5, 1 µM solvent: AcN AhR and via metabolites
16–18 Yes 20,71,126,127
Bisphenol A (BPA) 0, 0.5, 1, 2.5, 5 µM ER, AhR, PPAR, NF-κB 95,96 Yes 97,103,104
17α-Ethinylestradiol (EE2) 0, 0.25, 2.5, 5 µM solvent: EtOH ER
25–27 Yes 22,24,91,128
Ethylene glycol (EG) 0, 10, 25, 50, 75 mM polar narcotic; Verhaar class 2
129 No –
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a solvent was used), the solvent-free control was still assessed in the viability assay to exclude toxic effects due to 
the solvent itself (see Supplementary Material S6).
Terminology. For better reader-friendliness, the phrase “chemicals with immunotoxic potential” is short-
ened to “immunotoxicants”, the phrase “chemicals with no reported immunotoxic potential” to “non-immuno-
toxicants” through the paper. Besides, in this article we use the terms “immunomodulation” and “immunotox-
icity” synonymously. Nevertheless, we are aware that “immunomodulation” would be the more accurate term 
for chemical-induced alterations of fish immune parameters since such alteration does not necessarily imply 
an adverse, toxic effect on immunocompetence of the organisms. The term “cytotoxicity” is used to describe an 
acutely lethal effect of the test chemical on cell viability.
Fish husbandry and leukocyte isolation. Head kidney (HK) leukocytes from all-female, not yet repro-
ductively active rainbow trout (Oncorhynchus mykiss) of 777 ± 229 g body weight and 38 ± 4 cm total length were 
used in this study. Fish were obtained from “Pisciculture de Vionnaz Hess SA” (Switzerland) and maintained at 
the Centre for Fish and Wildlife Health, University of Bern, Switzerland. The experiment was approved by the 
ethical committee of the Canton of Bern under permit number BE 44/15. The study was performed in accord-
ance with relevant guidelines and regulations. The crucial assay parameters such as cell isolation, cell culture, cell 
density, incubation times and conditions for measuring phagocytosis, respiratory burst and cytokine transcrip-
tion, including the steps for qPCR analysis and lipopolysaccharide (LPS) stimulation were optimized in the con-
text of the applied study conditions. The protocol for HK leukocyte isolation was modified from Garduño and 
 Kay53 and Braun-Nesje et al.54: trout were euthanized with an overdose of buffered MS222 (tricaine mesylate) 
followed by a gill cut. The HK was removed, weighed and mechanically disaggregated using nets of 105 µm 
mesh size. The disaggregation was carried out under sterile conditions in an organ-weight dependent volume of 
medium (RPMI including 50 mM HEPES and 7 mM NaHCO3, pH 7.4) supplemented with 0.5% fetal bovine 
serum (FBS, heat inactivated, charcoal-stripped, sterile) and 10 U/ml heparin. The resulting suspension was 
centrifuged (450 rcf, 35 min, 4 °C) over a discontinuous Percoll gradient with 1.04 and 1.075 density. Leukocytes 
were collected from the interphase, washed twice (250 rcf, 10 min, 4 °C) with 10 U/ml heparin supplemented 
medium and once with non-supplemented medium. Cell number was adjusted to 1 × 106 viable cells/ml medium 
using trypan blue staining and a hemocytometer. Cells were then plated in 96-well plates (outer rows filled with 
cell-free medium) using medium supplemented with 0.5% FBS. The cell number per well depended on the effect 
parameter, see below for details. Cells were incubated overnight in a humid and aerated cell incubator at 17 °C 
and further processed the next day.
LPS stimulation and test chemical exposure. The conditions for stimulation were optimized in a 
series of prior tests using three different sources of LPS (O111:B4, O55:B5 and O26:B6) and beta-glucan and 
combinations thereof at different concentrations and exposure durations as well as prior and parallel to the 
chemical exposure (data not shown). Based on those results LPS from Escherichia coli 0111:B4 (final concentra-
tion 10 µg/ml  medium55) was added to half of the wells after the overnight incubation and incubated for 3 h to 
activate the immune cells. Subsequently, medium was removed from both non-stimulated and LPS-stimulated 
cells. Leukocytes were then exposed to a range of concentrations of the test chemicals in fresh, LPS- and FBS-
free medium for a short-term (3 h) or long-term (19 h) period. Each test chemical was measured in five to seven 
independent biological replicates (= fish). The numbers of biological replicates (fish n-numbers) utilized for 
statistical analysis are listed in Supplementary Material S4 for each test chemical and immune parameter. LPS 
treatment served as positive and quality control (see “Data analysis”). Within each individual biological repli-
cate, leukocyte exposure was performed in three technical replicates (= wells) for each treatment. The values of 
the technical replicates were averaged for statistical analysis. The amount of HK leukocyte obtained from one 
fish was quite limited, but we were still able to measure all parameters in each exposure scenario (short- and 
long-term exposure, without and with LPS stimulation) for one test chemical in parallel. Separate 96-well plates 
were used for long- and short-term exposure as well as for every parameter assessed.
Cytotoxicity assay to determine cell viability. To avoid interference of cytotoxicity with specific 
immunotoxic effects we determined the cytotoxic concentration range for each chemical prior to the main 
experiments. To this end, the cells were exposed for 3 and 19 h to a concentration series of each test chemical, 
with and without prior LPS stimulation. During the main experiment, cell viability was monitored in parallel to 
the immune parameters. Cell viability was measured using Calcein-AM (calcein acetoxymethyl ester, final con-
centration 1 µM, 30 min incubation, 1.5 × 105 cells/well, modified from Lilius et al.56). The value was normalized 
to the total number of cells as determined by means of DAPl nuclei staining (4′,6-diamidino-2-phenylindole 
dihydrochloride, final 5 µg/ml, 2 h incubation). Dye intensity was scanned over the entire well-bottom in a 2300 
EnSpire Multilabel Plate Reader (PerkinElmer) at λ 495 nm/517 nm for Calcein-AM and λ 358 nm/461 nm for 
DAPI. Data was normalized against the blanks (cells without dye). Test chemical concentrations that resulted 
in more than 80% cell viability (equivalent to < 20% cytotoxicity,  EC20Cytotox) in the range finding were used to 
evaluate the immune parameters and to run the in silico modelling in the main experiment.
Phagocytosis activity. The phagocytosis activity was evaluated with a method adapted from Harford 
et  al.57. Leukocytes (2.5 × 105  cells/well) were simultaneously exposed to the test chemical and 1  µm yellow-
green-fluorescently labeled latex beads (cell:bead ratio of 1:12). Accordingly, cells were allowed to ingest beads 
for 3 h or 19 h, depending on the exposure conditions. Afterwards, cells were placed on ice to prevent further 
phagocytosis. Beads were then added to three wells of non-exposed, control leucocytes which represented the 
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blanks. The blanks were used to correct for potential uptake or attachment of beads to the surface of the cells 
that may have happened during the short time between placing the cells on ice and the flow cytometry measure-
ment. Next, the supernatant of each well was transferred into an individual 1.5 ml tube and cells were detached 
from culture plates using trypsin. The resulting cell suspension was added to the supernatant and centrifuged 
at 200  rcf and 4  °C for 8  min. The supernatant was discharged by pipetting and cells were re-suspended in 
fresh chemical- and bead-free medium. Subsequently, 10,000 cells were measured in a flow cytometer. Experi-
ments with dexamethasone, ethinylestradiol and trichlorobenzene were analyzed on a BD FACSCanton II flow 
cytometer, the other experiments on a BD LSR II which broke during the study, but results were similar for both 
devices. This was confirmed by repeating a bisphenol A exposure and analyzing it on the BD FACSCanton II.
The percentage of phagocytosis-active cells was determined as follows using the software program FlowJo 
v10: cells of interest were selected (= gated) in a forward scatter (FSC) vs. side scatter (SSC) plot. Based on their 
forward and sideward properties, gates were placed around myeloid-like and lymphocyte-like cells as well as a 
third gate for both cell types together (“all cells”). Within the selection, propidium iodide negative (final con-
centration 3 µM), single cells (FSC-A vs. FSC-H) that additionally stained for FITC (fluorescein isothiocyanate, 
detection of the beads) were considered to represent the number of phagocytosis-active cells which ingested at 
least one bead. Data obtained was normalized against the blanks. The data presented in this study is based on the 
phagocytic activity of the myeloid-like cell fraction such as granulocytes and macrophages. Initially, the three 
gates of the FSC-SSC-plot were analyzed individually and data for myeloid-like cells yielded the clearest pattern 
although results were similar for all approaches. This is in accordance with results of other studies: cells that 
sense pathogens through receptors such as granulocytes (myeloid-like) are particularly active ingesting foreign 
 particles58 even though fish lymphocytes conduct phagocytosis,  too59–61. Initially, data for myeloid-like cells were 
additionally analyzed according to the number of ingested beads: (a) one, (b) two or (c) three and more beads. 
Results obtained were similar to analysis results on phagocytosis independent of the number of ingested beads. 
Thus, the latter is presented in this article.
Respiratory burst activity. During a respiratory/oxidative burst, leukocytes generate reactive oxygen spe-
cies (ROS) to attack phagocytosed pathogens. The impact of chemical exposure on the respiratory burst activity 
of leukocytes was assessed using a nitro blue tetrazolium (NBT) assay adapted from Rymuszka and  Adaszek62: 
after chemical exposure the 96-well plates were centrifuged (300 rcf, 2 min) and leukocytes (2 × 105 cells/well) 
were incubated for 2 h in fresh, chemical-free medium containing 1 mg/ml NBT. Afterwards, plates were centri-
fuged (300 rcf, 2 min) and medium was replaced by 100% MeOH for 2 min. MeOH was removed after additional 
centrifugation (300 rcf, 2 min). 2 M KOH and DMSO were added to the dried wells, mixed to dissolve crystals 
and plates were centrifuged (300 rcf, 2 min). An aliquot (150 µl) of the supernatant was transferred into a clean 
well and photometrically measured at λ 630 nm. Data was normalised against the blanks (cells without NBT).
qRT-PCR analysis of cytokine mRNA transcript levels. To assess the effect of chemical exposure on 
the cytokine mRNA transcript level (IL-1β, TNFα and IL-10), quantitative real-time PCR (qRT-PCR) analysis 
was conducted. In a series of prior tests, we evaluated the suitability of different RNA extraction kit, optimized 
the RNA extraction, assessed the quality of the extracted RNA by using the bioanalyzer methodology and we 
optimized the cDNA synthesis as well as the qPCR protocol. For the measurements, the 96-well plates (2 × 105 
cells/well) were centrifuged (300 rcf, 2 min) after chemical exposure, medium was removed and plates were sub-
sequently stored at – 80 °C. Only cells from the control and the highest chemical concentration were analyzed. 
RNA was extracted using the ReliaPrep RNA Cell Miniprep System (Promega) with two modifications: (I) RNA 
was extracted from pooled cells of two technical replicates per treatment by consecutive centrifugation of rep-
licates on the same extraction column. (II) RNA was eluted from the extraction column using two times 7.5 µl 
nuclease-free water. RNA yield was estimated using the NanoDrop 1000 spectrophotometer (Witec AG). For 
cDNA synthesis, 100 ng RNA were used and the GoScript Reverse Transcription Mix, Random Primers (Pro-
mega) protocol was followed. For qRT-PCR analysis the SYBR-green-type GoTaq qPCR Master Mix (Promega) 
protocol was applied with the following modifications: hot-start activation 5 min and 45 cycles. Sample compo-
sition are listed in Supplementary Material S1c, primer sequences are listed in Table 2 including references which 
evaluated the rainbow trout primers in the same lab as in which the present study was conducted. All samples 
were measured in technical duplicates using the 7500 Fast Real-Time PCR System (Applied Biosystems) and 
the SDS Software version 1.3.1 (Applied Biosystems). NTCs (negative controls, containing no cDNA but water) 
and melting curves were carried out for each plate to exclude contamination or erroneous amplification. For 
data analysis the threshold (i.e. signal exceeds background level) was set at Ct 0.2 and the baseline between cycle 
3–15. Calculations were made using the  2−ΔΔCt method. We analyzed transcript levels of two reference genes, 18S 
Table 2.  Primer sequences and corresponding references.
Gene Forward primer (5′–3′) Reverse primer (5′–3′) References
18S TGC GGC TTA ATT TGA CTC AACA CAA CTA AGA ACG GCC ATG CA 136
EF-1α TGC CCC TGG ACA CAG AGA TT CCC ACA CCA CCA GCA ACA A 137
IL-10 CTG CTG CTC CTT CGT AGA GG CTC GTC ATT AGC CTC GTA GTA GTC TC 138
IL-1β AGT GCT GTG GAA GAA CAT ATA GTG TTG CAT CAG GAC CCA GCA CTT G 138
TNFα1+2 AGG GGA CAA ACT GTG GAC TG GTG CAA ACA CAC CAA AGA AGTT 138
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and EF-1α. Although expression of both reference genes was stable, EF-1α expression showed less variability 
between time points and between treatments and controls, thus data was normalized to EF-1α. Mean Ct values 
for EF-1α are displayed for all test chemicals in Supplementary Material S1d. The effects on cytokine expression 
are expressed as fold change in relation to the control (= 1) of each fish to account for possible variation between 
fish in the basal expression level.
In silico modelling to determine baseline toxicity and degree of specificity of the effect. In 
order to confirm if the immune responses were specific or caused by non-specific toxicity (baseline toxicity or 
narcosis) we predicted the inhibitory concentrations for baseline toxicity of the test chemicals and compared 
them to their experimentally determined effect concentrations. All baseline toxicants have a critical membrane 
concentration of approximately 69 mmol/Lmembrane lipid that triggers 10%  cytotoxicity51. This critical membrane 
concentration can be converted to nominal  IC10baseline  toxicity with a mass balance model that accounts for the 
distribution of the chemicals between medium components and uptake into cells and cell  membranes51. The 
 IC10baseline toxicity depends on the medium composition and the cell make-up in terms of lipid and protein content. 
Model input parameters such as protein and lipid content were taken from Fischer et al.63 and adapted to the cells 
and medium used here. The distribution constants between protein and water Dproteinw and between membrane 
lipids and water Dlipw at pH 7.4 for all test chemicals are listed in the Supplementary Material S2. This model 
does not account for evaporative losses, so the trichlorobenzene (TCB), whose loss to air might be as large as 
90%, was omitted from this analysis. All other chemicals were not expected to be lost to the headspace (calcu-
lated according to Escher et al.51, data not shown). The model also does not account for sorption to the plastic 
of well-plates because, as we recently showed, binding to polystyrene is a kinetically controlled process and in 
presence of sufficient lipids and proteins the loss is negligible for the chemicals tested because the freely dissolved 
concentration that would bind to the polystyrene is very  small64. The  EC20Cytotox represents the concentration 
at which the measured cell viability decreased below 80%—equivalent to < 20% cytotoxicity (EC: effect concen-
tration). This threshold was used to determine the non-cytotoxic concentrations range of test chemicals of the 
present study and thus, was used for the in silico modelling, too. This experimentally measured cytotoxicity 
 (EC20Cytotox) was plotted versus the predicted  IC10baseline toxicity (Fig. 1). The toxic ratio (TR), which expresses the 
ratio between calculated  IC10baseline toxicity and the measured  EC20Cytotox of the present study, was used to identify 
if the cytotoxicity was caused by a specific MoA (TR > 10) or was non-specific (TR ≤ 10) cf.65. The specificity ratio 
(SR) is an indicator of how much more potent the specific effect of the test chemicals is compared to the cyto-
toxicity (SR < 10 indicates non-specific action)52. The SR of the present study was calculated as the ratio of the 
Figure 1.  Comparison of the  EC20Cytotox for measured cytotoxicity with baseline toxicity predictions 
 (IC10baseline toxicity). The immunotoxic chemicals are dexamethasone (Dex), diclofenac (DCF), benzo(a)pyrene 
(BaP), bisphenol A (BPA) and ethinylestradiol (EE2), the non-immunotoxicants are ethylene glycol (EG) and 
butanol (But). For BaP the highest tested concentration was used since all chemical concentrations were in the 
non-cytotoxic range, thus, the  EC20Cytotox was not determinable. TR ≤ 10 indicates that cytotoxicity was caused 
by a non-specific mode of action. TR toxic ratio, EC effect concentration.
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 EC20Cytotox to the  LOECimmune parameter. The  LOECimmune parameter corresponds to the lowest concentration for which 
the chemical-induced effect on an immune parameter, compared to the control, had a p value ≤ 0.05 (thus, the 
 LOECimmune parameter was not available for all endpoints and chemicals).
Data analysis. For the final statistical analysis we assumed that the effects of LPS, the exposure period and 
the level of chemical concentration act additively to measured immune parameters. Usually, synergy and antago-
nism come from toxicokinetics and it is unlikely that this is noticeable in pure cell culture systems. In addition, 
a recently published study demonstrated that below 10% the prediction of concentration addition and inde-
pendent action are  identical66. The model applied in the present study includes a different base level of immune 
system activity for every fish in order to account for differences between the individuals. All other effects are 
estimated jointly for all fish. The model equation was as follows:
For an immune system activity parameter (or assay) Y, the ith observed value is modeled as
where
All βi are parameters to be estimated.
As the effects cannot be seen in isolation, the model includes interaction terms between all effects. This 
results in a maximum of 17 parameters: one intercept, six for the fish base level, one for the direct LPS effect, 
one for the effect of the time point, up to three for the concentration level and maximal five for the interactions. 
A direct interpretation of these model parameters is not intuitive. For this reason, we applied Wald tests to test 
meaningful linear combinations of the model parameters (e.g.67). This enabled us to test the difference between 
relevant conditions. The models were estimated with the linear model function in R 3.4.168 and the R package 
“contrast”69 was applied to test the linear combination of the parameters. The R-code of the model can be found 
in the Supplementary Material S3. The LPS treatment served as positive and quality control: results were con-
sidered valid and included in the data analysis if LPS caused a stimulation of control cells which was higher than 
in non-stimulated cells and, additionally, exceeded the technical error (R-code step 2 line 23 in Supplementary 
Material S3). If those criteria were not fulfilled, fish were excluded from the data analysis. The calculated standard 
deviations for selecting valid data and the resulting n-numbers for each chemical and immune parameter are 
listed in the Supplementary Material S4. For the qRT-PCR analysis the statistical analysis was done based on 
the ΔCt values. Diagnostic plots confirmed that the model assumptions were fulfilled well (see Supplementary 
Material S5). If the p value was below 0.05 statistical significance was accepted.
Results
The  EC20Cytotox value of each exposure scenario (short- and long-term exposure, without and with LPS stimula-
tion) and test chemical was compared with respective predicted  IC10baseline toxicity in Fig. 1 to determine the toxic 
ratio (TR). The predicted  IC10baseline toxicity and the average  EC20Cytotox derived from the four exposure scenarios 
are given in Table 3, the individual values for each exposure scenario are displayed in Fig. 1. A TR ≤ 10 indicates 
that the cytotoxicity was caused by a non-specific MoA (see above). Since all TR values were below or very close 
to 10 (TR = 11 for diclofenac), the cytotoxicity of all chemicals was due to non-specific baseline toxicity (Table 3). 
Results of the cytotoxicity assays are shown in Supplementary Material S6.
Immuno-assay responses to the reference chemical dexamethasone. Dexamethasone was used 
as reference compound as it is a synthetic derivative of cortisol and a well-established immunosuppressive agent 
for fish. The immune parameter results for dexamethasone are presented as boxplots in Fig. 2. Detailed results of 
the statistical analyses are provided in Supplementary Materials S7–S9.
Phagocytosis. Dexamethasone significantly suppressed the phagocytosis activity in a concentration-dependent 
manner. This was the case for non-stimulated and for LPS-stimulated leukocytes as well as after short- (p val-
ues < 0.05, not significant for non-stimulated cells after 3 h of 1 μM and 10 μM) and long-term exposure (all p 
values < 0.001, Fig. 2a). LPS caused a significant increase in phagocytosis activity (p value < 0.001 for 19 h).
Respiratory burst activity. Dexamethasone significantly suppressed the respiratory burst activity in a concen-
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short- and long-term exposure (p value < 0.05 for 3 h, 1 μM without LPS, all other p values < 0.001, Fig. 2b). LPS 
caused a significant stimulation in the respiratory burst activity (p value < 0.01 and < 0.001 for 3 h and 19 h).
Cytokine transcription. Dexamethasone significantly decreased the mRNA transcript levels of the two pro-
inflammatory cytokines, IL-1β and TNFα. This was the case for non-stimulated and for LPS-stimulated cells as 
well as after short- and long-term exposure (all p values < 0.001, except for IL-1β, 3 h, without LPS (not signifi-
cant) and with LPS (p value < 0.01; Fig. 2c,d)). Transcription of the anti-inflammatory cytokine IL-10 was signifi-
cantly reduced in the short-term exposure scenario with non-stimulated cells (p value < 0.05). For the long-term 
exposure, the IL-10 mRNA level was significantly increased in stimulated (p value < 0.01) and non-stimulated 
(p value < 0.05) leukocytes (Fig. 2e). LPS caused a significant induction of the gene transcription for IL-10 (p 
value < 0.01 after 19 h) and IL-1β (p value < 0.001 and < 0.05 for 3 h and 19 h).
Immuno-assay responses to all test chemicals. Results of all test chemicals are summarized in Fig. 3 
and provided in detail as boxplots in Supplementary Material S10. Detailed results of the statistical analyses 
are provided in Supplementary Material S7–S9 and additional information on the response pattern analysis is 
described in Supplementary Material S11.
Phagocytosis. Of the substances known to modulate the fish immune system, the compounds dexametha-
sone (see above), ethinylestradiol (EE2, p values < 0.01 and < 0.001 for 3 h and 19 h) and bisphenol A (BPA, p 
value < 0.05 for 19 h) significantly inhibited the phagocytosis activity (Fig. 3, column 2 and 3). For diclofenac 
(DCF) and benzo(a)pyrene (BaP), a trend towards reduced phagocytosis was observed (Fig. 3, column 2 and 
3). Exposure to the non-immunotoxicant ethylene glycol (EG) resulted in a significant stimulation of phagocy-
tosis activity (p values < 0.001 and < 0.05 for 3 h and < 0.001 and < 0.01 for 19 h). Butanol, in contrast, caused a 
significant inhibition of phagocytosis activity (p values < 0.01 and < 0.001 for 3 h and twice < 0.001 for 19 h). In 
general, the phagocytosis activity of leukocytes in all experiments was significantly higher after long-term than 
short-term exposure (p value < 0.001; S7: no. 3, 4, 11, 12), but this was independent of the general response pat-
tern, i.e. if the test chemical lowered phagocytosis activity after short-term exposure, it also did after long-term 
exposure (Fig. 3). LPS treatment significantly increased phagocytosis activity in all long-term treatments (Fig. 3, 
column 1; p values < 0.001 except BPA and But with p values < 0.05).
Respiratory burst activity. Benzo(a)pyrene (p values < 0.001 for 3 h; < 0.01 and < 0.05 for 19 h) and bisphenol A 
(p values < 0.001 and < 0.05 for 3 h; twice < 0.001 for 19 h) significantly increased respiratory burst activity (Fig. 3, 
column 2 and 3). In contrast, ethinylestradiol (p values < 0.001 except p value < 0.01 for non-stimulated cells, 3 h) 
and dexamethasone (see above) exposure resulted in a significant inhibition of respiratory burst activity without 
and with LPS stimulation at both time points. Diclofenac had no significant effects. The non-immunotoxicants, 
ethylene glycol (p value < 0.05 for stimulated cells, 3 h; < 0.05 and < 0.01 for 19 h) and butanol (p value < 0.01 for 
stimulated cells, 3 h; < 0.05 and < 0.001 for 19 h), resulted in a significant inhibition of respiratory burst activity 
for both exposure periods. This effect was stronger in LPS-stimulated leukocytes. LPS significantly stimulated 
the respiratory activity (p values < 0.05 for But and EE2 (19 h), p values < 0.01 for BPA (3 h), EE2 (3 h), BaP 
(19 h), p values < 0.001 for EG; Fig. 3, column 1).
Cytokine transcription. For IL-1β transcription, significant inhibitions were detected after exposure to dexa-
methasone (see above), benzo(a)pyrene (p value < 0.001 for stimulated cells, 19 h), bisphenol A (p values < 0.01 
for non-stimulated cells at 3 h, < 0.001 and < 0.05 for 19 h) and ethinylestradiol (p values < 0.05 and < 0.01 for 
19 h) as well as after exposure to ethylene glycol (p values < 0.001 for stimulated cells, 19 h) and butanol (p 
values < 0.01 and < 0.001 for 19 h). The inhibition was more pronounced after long-term exposure than after 
short-term exposure (Fig. 3, column 2 and 3). TNFα transcription was significantly stimulated by butanol, after 
3 h in non-stimulated cells (p value < 0.01) but inhibited by dexamethasone (see above). The mRNA transcript 
level of IL-10 was significantly altered by dexamethasone (see above) and increased in response to bisphenol A 
(p value < 0.05 for stimulated cells, 3 h) and diclofenac (p value < 0.05 for non-stimulated cells, 19 h).
Table 3.  Predicted  IC10Cytotox, average  EC20Cytotox (derived from short- and long-term exposure, without and 
with LPS) and the calculated toxic ratio (TR).
Test chemical IC10baseline toxicity (µM) Average  EC20Cytotox (µM) TR
Dexamethasone (Dex) 1515 400 3.8
Diclofenac (DCF) 5044 463 10.9
Benzo(a)pyrene (BaP) 20  > 2 –
Bisphenol A (BPA) 68 25 2.7
Ethinylestradiol (EE2) 60 31 1.9
Ethylene glycol (EG) 977,000 1,000,000 1.0
Butanol (But) 26,000 100,000 0.3
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Figure 2.  Effects of the reference compound dexamethasone on the immune parameters: phagocytosis (a), 
respiratory burst (b) and the mRNA transcript levels of IL-1β (c), TNFα (d) and IL-10 (e). Results are shown 
after short- and long-term exposure with dexamethasone—without (gray) or with (yellow) previous LPS 
stimulation. Significant differences of the chemical treatments compared to the respective controls are indicated 
with gray or yellow asterisks, respectively. Significant differences of the control without LPS compared to the 
control with LPS are indicated with orange asterisks. p values < 0.001 for ***; < 0.01 for ** and < 0.05 for *.
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The  LOECimmune parameter were compared with the respective  EC20Cytotox for each exposure scenario (short- and 
long-term exposure, without and with LPS stimulation) to determine the specific ratio (SR, Fig. 4; numerical 
values listed in Table 4). The SR indicates how much more potent the immunotoxic activity of the test chemicals 
is compared to its cytotoxic activity. The average  LOECimmune parameter of the four exposure scenarios (short- and 
long-term exposure, without and with LPS stimulation) is given for each immune parameter and test chemical in 
Table 4, the average  EC20Cytotox for the four exposure scenarios in Table 3. The reference compound dexametha-
sone acted highly specific on the phagocytosis and respiratory burst activity, as indicated by SR > 100. Almost 
all other chemicals showed an SR > 10, being moderately specific on the phagocytosis (except BPA with SR = 8). 
For respiratory burst activity, SRs were lower than for phagocytosis activity, but mostly above 10. In contrast, SR 
values for the transcript level of the three cytokines had low SRs for the reference compound dexamethasone 
(SR ≤ 50) and did not show SR > 10 for the other test compounds, suggesting that chemical action was rather 
non-specific for those parameters.
Discussion
The aim of the present study was to examine if an in vitro assay using isolated fish leukocytes is suitable to screen 
for immunotoxic potentials of environmental chemicals to fish and to discriminate those against chemicals with 
no known immunotoxic action. We exposed the leukocytes at non-cytotoxic concentrations in a short- (3 h) and 
long-term (19 h) exposure scenario, each without and with previous LPS stimulation. As endpoints indicative 
of immunotoxic activity of the test compounds, we selected those parameters that were identified in a previous 
 review45 as the most frequently measured parameters in fish immunotoxicity studies: phagocytosis activity, 
oxidative burst activity and cytokine production. While the former two parameters could be stably measured in 
our in vitro assay, the cytokine transcript levels showed high interindividual variability what limits their value 
as immunotoxicity indicators but does not affect the overall conclusion of our study.
Differences between short- and long-term exposures were found particularly for the phagocytosis activity and 
the cytokine responses. In the case of the immune gene transcription the difference between short- and long-term 
Figure 3.  Overview of the in vitro immuno-assay results. Depictured are the results for the comparison of the 
LPS-stimulated control to the non-stimulated control (column 1 of each immune parameter) and the results for 
the comparison of the highest applied chemical concentration without (column 2) and with LPS stimulation 
(column 3) compared to the control without or with LPS stimulation, respectively. Data is displayed for short- 
(top) and long-term (bottom) chemical exposure separately. Colors represent the p values of the comparisons 
with underlying decreasing effects in red and for increasing effects in green in relation to the corresponding 
control. If the p value was below 0.05, statistical significance was accepted. The reference compound 
dexamethasone (Dex), the other immunotoxicants (DCF diclofenac, BaP benzo(a)pyrene, BPA bisphenol A and 
EE2 ethinylestradiol) and the non-immunotoxicants (EG ethylene glycol and But butanol) were clustered with 
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Figure 4.  Comparison of the  LOECimmune parameter with the experimental cytotoxicity  EC20Cytotox. The 
immunotoxicants are dexamethasone (Dex), diclofenac (DCF), benzo(a)pyrene (BaP), bisphenol A 
(BPA) and ethinylestradiol (EE2); non-immunotoxicants are ethylene glycol (EG) and butanol (But). The 
 LOECimmune parameter was not available for all endpoints and chemicals since only chemical-induced effect on 
immune parameter with a p value ≤ 0.05 were considered. SR > 10 indicates specificity for chemical effects on 
immune parameter. SR specific ratio, LOEC lowest observed effect concentration, EC effect concentration.
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exposures is probably due to biological mechanisms such as the involvement of different signaling pathways: for 
instance, time-dependent differences of the immunomodulating effects of ER-ligands have been reported for 
carp leukocytes. The time dependency may relate to the differential activation of (fast) non-genomic and (slow) 
genomic signaling  pathways70. The effects seen for the phagocytosis activity are likely due to a technical issue: 
after 3 h of bead-exposure the percentage of phagocytosis-active cells in the total cell population was still very 
low and this translated into an instable measurement signal. After 19 h the percentage of phagocytosis-active 
cells had clearly increased, giving rise to a more stable signal.
The LPS-treatment of the leukocytes caused stimulation of the phagocytosis, respiratory burst activity and 
cytokine transcripts. Our findings of the LPS effects on the immune parameters are in line with results of other 
studies and reflect the stimulatory action of bacterial antigens on the immune  cells71–80. Thus, LPS treatment 
could serve as positive and quality control for the validity of cell isolations (see “Data analysis”).
The reference compound, dexamethasone, is an activator of the glucocorticoid receptor (GR) pathway. In 
our experiments, dexamethasone induced the expected responses. Regulation of GR by glucocorticoids in fish 
leukocytes has been demonstrated  previously81,82. The significant inhibition of phagocytosis and respiratory burst 
activity observed in our study is in line with findings of other studies (e.g.31–33,83–85). For the transcript levels 
of the cytokines we observed a reduction of the pro-inflammatory IL-1β and TNFα, together with a significant 
stimulation of the anti-inflammatory IL-10. The anti-inflammatory IL-10 is mainly involved in the attenuation 
of activated immune responses, in contrast to the pro-inflammatory  cytokines86–90 thus, the observed opposite 
reaction patterns of the pro- and anti-inflammatory cytokines were to be expected. Together with this LPS results 
the findings from the dexamethasone experiments confirm the validity of the in vitro assay as performed in the 
present study.
Ethinylestradiol and bisphenol A displayed immunomodulating activities in the in vitro leukocyte assay. In 
line with our findings, these two estrogen-active compounds were found to influence the immune system of fish 
in a number of previous  studies28,91–97. They mediate their effects probably via estrogen receptors (ER), which 
are known to be expressed in fish immune  cells27,70,95,96,98.
Benzo(a)pyrene significantly stimulated the respiratory burst activity and significantly inhibited the tran-
scription of IL-1β in the in vitro immuno-assay. Benzo(a)pyrene has a well-documented immunomodulating 
activity in fish including rainbow  trout16–18. Its MoA involves the activation of the arylhydrocarbon receptor 
(AhR) which is a central regulator of various immune pathways and  functions99 and known to be expressed 
in fish  leukocytes100–102. Moreover, our findings on the immunomodulating properties of selected ER and AhR 
ligands in isolated trout leukocytes are corroborated by findings on ER- and AhR-mediated effects in other fish 
species such as sea bream, rare minnow and  carp22,71,103–105.
Diclofenac had a weak effect in our in vitro immuno-assay. This was unexpected since diclofenac is 
a widely used pain killer with anti-inflammatory and immunosuppressant properties (e.g.106). Studies with 
fish demonstrated that it indeed modifies the expression level of cyclooxygenase (COX) and further immune 
 parameters30,32,107. Nevertheless, evidence from mammalian studies suggest that diclofenac may not directly inter-
fere with phagocytotic and respiratory activity. In cultured mice macrophages, COX inhibitors such as diclofenac 
enhanced zymosan-stimulated phagocytosis but had only a minor effect on the respiratory  burst108. Neumüller 
and Tohidast-Akrad109 found only a slight increase in phagocytosis activity after exposing human peripheral 
blood leucocytes to diclofenac. In an invertebrate species, the freshwater mussel Elliptio complanate, no correla-
tion between the effect of diclofenac on COX and phagocytosis could  detected110. The finding that diclofenac had 
only a weak effect in our leukocyte assay highlights how important it is to consider the application domain of an 
Table 4.  Average  LOECimmune parameter and average specific ratios (SR) for the immune parameters. The 
averages are derived from the values for short- and long-term exposure, each without and with LPS. n.d. not 
determinable, SR specific ratio, LOEC lowest observed effect concentration.
Test 
chemical
Phagocytosis activity Respiratory burst activity IL-1β transcription TNFα transcription IL-10 transcription
Average 



























2 300 1 400 10 37 10 40 10 50
Diclofenac 




n.d 0.75 3.5 1 1 n.d n.d
Bisphenol 




2 35 3 11 5 7.5 n.d n.d
Ethylene 
glycol (EG) 17,500 85 66,667 17 75,000 7 n.d n.d
Butanol 
(But) 5,625 18 5,833 18 10,000 10 10,000 10 n.d
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assay: the assay used in the present study appear to be well able to screen for chemicals such as dexamethasone, 
ethinylestradiol, bisphenol A or benzo(a)pyrene that exert their immunological activity through receptors, but 
it may be less suitable for chemicals such a diclofenac which modulate the immune cells through other MoA.
The non-immunotoxicants, butanol and ethylene glycol, induced significant responses of at least some of the 
immune parameters. We tested a third baseline toxicant, 1,2,4-TCB, which was retrospectively excluded from 
the study. Due to its high volatility, the active concentration of TCB in the assay was difficult to control. Never-
theless, TCB, like butanol and ethylene glycol, evoked reactions in the immuno-assay (Supplementary Material 
S10). The observation that these baseline toxicants with no known immune activity still induce responses of 
the immune parameters in the in vitro leukocyte assay is in contradiction to our original expectation that the 
assay would discriminate between immunotoxicants and non-immunotoxicants. On the contrary, the in vitro 
assay would falsely classify ethylene glycol, butanol and TCB as potential immunotoxicants. It is acceptable that 
a screening assay produces false positive classifications, but the question is what percentage of false positives is 
acceptable? A too high percentage would disqualify the assay. On the basis of our study this question cannot be 
conclusively answered. It would need an extended testing of additional chemicals to conclude on the specificity 
of the in vitro fish leukocyte assay.
Is there a possible explanation for this lack of discrimination between immunotoxicants and non-immuno-
toxicants by the in vitro assay? The simplest explanation would be that we tested at concentrations that cause 
cytotoxicity. This, however, does not apply since we selected non-cytotoxic concentrations. Thus, other mecha-
nisms must be responsible for the immunological activities of low concentrations of narcotic chemicals in the 
leukocyte assay. The assumption is supported by our in silico modeling as the SR for the non-immunotoxicants 
indicated a rather specific but not a cytotoxicity-driven action. Since we did not find any indication in the lit-
erature that those chemicals act via direct interference with immune system components, the observed effects 
might be rather based on an indirect action. Baseline or narcotic toxicity arises from the non-specific intercala-
tion of these chemicals into the (phospho-)lipid layers of biological membranes thereby interfering with their 
normal  functioning111. At high concentrations the chemical-induced disturbances lead to the loss of the barrier 
function of the cell membrane, eventually resulting in cell death. At low concentrations, the induced alterations 
of the cell membrane might be subtle but sufficient to cause osmotic stress to the cell and, associated with this, 
the modulation of cell membrane-associated signaling cascades such as ERK (extracellular signal-regulated 
kinases), JNK (c-Jun N-terminal kinase), MAPK (mitogen-activated protein kinase) or NFAT5 (Nuclear factor of 
activated T-cells 5)112–114. These signaling cascades function as stress sensors of the  cell115–117 and they often con-
verge with NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B-cells) signaling. NF-κB is involved 
in the cellular stress  response117 but at the same time is a central regulator of cellular immune  functions118–120. 
Besides, cell membrane disturbances can activate the heat shock/chaperone systems which can modulate immune 
 pathways121 or it may affect special regions of the cell membrane, the so-called lipid rafts. Lipid rafts were shown 
to be important organizing elements for immune signaling  receptors122. Hence, the observed immune effects of 
the non-immunotoxicants may be due to indirect mechanisms mediated via a non-specific disturbance of the 
membrane rather than via specific and targeted immunotoxic MoAs. In the present study, only three narcotics 
were tested thus, the aforementioned considerations are highly speculative, but it may be worthwhile to inves-
tigate the suggested mechanism in future studies.
In conclusion, the present study provides a systematic evaluation of a potential fish immunotoxicity screen-
ing assay. A set of test compounds containing non-immunotoxic chemicals and toxicants with different modes 
of immunotoxic action were assessed under the same test conditions using identical effect parameters. From 
the results it appears that the in vitro fish leukocyte assay, as performed in the present study, has only a limited 
capacity for discriminating between immunotoxicants and non-immunotoxicants. Thus, this assay is not suitable 
as “stand alone assay” for immunotoxicity screening. Since the fish immune system is too complex to be repre-
sented by only one assay, it will need a battery of complementary assays (cf.34), as it is realized in the guidelines 
for human immunotoxicity  testing123. To identify a test battery for fish immunotoxicity screening the systematic 
evaluation as conducted in the present study needs to be applied to further candidate parameters and assays.
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